Suzhou Tianlu Bio-pharmaceutical Co., Ltd.

Specialized in producing medicine intermediates including Ursodeoxycholic Acid (UDCA), Chenodeoxycholic Acid (CDCA), Hyodeoxycholic Acid (HDCA), pancreatin, kallikrein, Cholic Acid (CA) and Bilirubin, etc. Those products can be made in compliance with a named pharmacopoeia standard as such USP, BP, EP, JP or CP, or be customised by the customers requirements.

Activity:

- Contract Manufacturing
- Manufacturing
- Research & Development
- Sales & Distribution

Product / Technology type(s) covered:

- Enzymes
- Pharmaceuticals / Therapeutics

Therapeutic targets:

- Gastrointestinal
- Infectious Diseases
- Men's Health
- Women's Health

Markets Covered

a. HeadQuarter: China

b. Continent(s) active: Europe , North America , Asia , Near/Middle East , Central/South America

c. Countries active: EU, America

Corporate data:

Number of Employees: 98

Turnover:

Amount:	Year:	Currency:
10 million	2002	US Dollar

Year founded: 1999